CC
HZNP

Carlson Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Carlson Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-624,432
Closed -$72.2M – 180
2023
Q3 		$72.2M Sell
624,432
-66,844
-10% -$7.18M 5.63% 3
2023
Q2 		$71.1M Sell
691,276
-134,724
-16% -$14.2M 6.09% 2
2023
Q1 		$90.1M Buy
826,000
+71,000
+9% +$7.85M 8.47% 2
2022
Q4 		$85.9M Buy
+755,000
New +$62.7M 6.56% 2
2016
Q3 		– Sell
-221,000
Closed -$3.64M – 332
2016
Q2 		$3.64M Buy
+221,000
New +$3.58M 0.05% 240

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Carlson Capital's HZNP Position: Q4 2023 in Review

Carlson Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 624,432 shares — an estimated $72.2M sold.

Carlson Capital first reported a position in HZNP in Q2 2016 and held it in 5 quarters. The position peaked at $90.1M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Carlson Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Carlson Capital sold 624,432 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $72.2M.
  • Carlson Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2016 and held it in 5 quarters.
  • Carlson Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $90.1M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Carlson Capital's 13F filing for Q4 2023, filed 13 Feb 2024.